PE/Cy5® Anti-CD40 antibody [1C10]
Be the first to review this product! Submit a review
|
(3 Publications)
Rat Monoclonal CD40 antibody - conjugated to PE/Cy5®. Suitable for IP, Flow Cyt, FuncS and reacts with Mouse samples. Cited in 3 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CD40.
View Alternative Names
CD40, TNFRSF5, Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, CDw40
- Flow Cyt
Supplier Data
Flow Cytometry - PE/Cy5® Anti-CD40 antibody [1C10] (AB25044)
BALB/c mouse splenocytes were stained with Rat Anti- Mouse CD40-PE/Cy5 (ab25044). The grey peak represents an isotype control. The purple peaks represents the negative (Left) and positive (right) datasets.
Reactivity data
Product details
This antibody closely resembles the gp39/CD40 ligand in its ability to stimulate proliferation of small, resting B lymphocytes in the absence of other cofactors.
This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5, 268, 486 and related patents. Cy® and CyDye® are trademarks of Cytiva.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 24: PubMed37108601
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:745939 PubMed34616407
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed33255183
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com